$GERN
Geron Corp

2021 Q4 Form 10-K Financial Statement

#000156459022009627 Filed on March 10, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $1.040M $1.393M $50.00K
YoY Change 1980.0% 450.59% -70.76%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.872M $29.67M $7.090M
YoY Change 11.03% 15.52% 34.79%
% of Gross Profit
Research & Development $24.15M $85.73M $16.23M
YoY Change 48.8% 66.5% -34.87%
% of Gross Profit
Depreciation & Amortization $61.00K $215.0K $50.00K
YoY Change 22.0% 36.08% 150.0%
% of Gross Profit
Operating Expenses $32.02M $115.4M $23.32M
YoY Change 37.32% 49.54% -22.73%
Operating Profit -$114.0M
YoY Change 48.22%
Interest Expense -$1.029M $3.740M -$690.0K
YoY Change 49.13% 392.11% -173.4%
% of Operating Profit
Other Income/Expense, Net -$6.000K -$133.0K $170.0K
YoY Change -103.53% -179.17% -1800.0%
Pretax Income -$32.02M -$116.1M -$23.79M
YoY Change 34.58% 53.55% -18.16%
Income Tax
% Of Pretax Income
Net Earnings -$32.02M -$116.1M -$23.79M
YoY Change 34.58% 53.55% -18.16%
Net Earnings / Revenue -3078.56% -8335.39% -47580.0%
Basic Earnings Per Share -$0.35
Diluted Earnings Per Share -$96.77K -$354.4K -$74.54K
COMMON SHARES
Basic Shares Outstanding 327.6M
Diluted Shares Outstanding 327.6M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $183.7M $183.7M $196.3M
YoY Change -6.4% -6.41% 40.88%
Cash & Equivalents $34.87M $34.87M $9.925M
Short-Term Investments $148.9M $148.9M $186.4M
Other Short-Term Assets $1.721M $1.721M $2.900M
YoY Change -40.66% -40.66% 93.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $187.2M $187.2M $199.9M
YoY Change -6.33% -6.35% 41.13%
LONG-TERM ASSETS
Property, Plant & Equipment $650.0K $5.377M $658.0K
YoY Change -1.22% -10.38% 61.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $28.65M $28.65M $63.40M
YoY Change -54.81% -55.02% 221.83%
Other Assets $4.800M $4.800M $1.500M
YoY Change 220.0% 300.0% 7.14%
Total Long-Term Assets $38.83M $38.83M $70.87M
YoY Change -45.21% -45.16% 196.42%
TOTAL ASSETS
Total Short-Term Assets $187.2M $187.2M $199.9M
Total Long-Term Assets $38.83M $38.83M $70.87M
Total Assets $226.0M $226.0M $270.7M
YoY Change -16.51% -16.5% 63.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.687M $6.687M $6.919M
YoY Change -3.35% -3.09% 485.86%
Accrued Expenses $29.83M $38.83M $14.93M
YoY Change 99.89% 61.81% 98.26%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $45.52M $45.52M $30.94M
YoY Change 47.13% 47.32% 9.86%
LONG-TERM LIABILITIES
Long-Term Debt $49.83M $49.83M $24.04M
YoY Change 107.26% 107.63%
Other Long-Term Liabilities $4.267M $4.267M $4.800M
YoY Change -11.1% -11.1% 118.18%
Total Long-Term Liabilities $49.83M $54.10M $24.04M
YoY Change 107.26% 87.84% 992.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $45.52M $45.52M $30.94M
Total Long-Term Liabilities $49.83M $54.10M $24.04M
Total Liabilities $99.62M $99.62M $59.78M
YoY Change 66.64% 66.59% 96.89%
SHAREHOLDERS EQUITY
Retained Earnings -$1.272B -$1.156B
YoY Change 10.05% 7.0%
Common Stock $1.398B $1.366B
YoY Change 2.33% 12.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $126.4M $126.4M $210.9M
YoY Change
Total Liabilities & Shareholders Equity $226.0M $226.0M $270.7M
YoY Change -16.51% -16.5% 63.57%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$32.02M -$116.1M -$23.79M
YoY Change 34.58% 53.55% -18.16%
Depreciation, Depletion And Amortization $61.00K $215.0K $50.00K
YoY Change 22.0% 36.08% 150.0%
Cash From Operating Activities -$22.17M -$95.56M -$12.61M
YoY Change 75.8% 43.37% 21.6%
INVESTING ACTIVITIES
Capital Expenditures -$103.0K $207.0K -$10.00K
YoY Change 930.0% -48.38% -88.89%
Acquisitions
YoY Change
Other Investing Activities $8.468M $72.15M -$21.83M
YoY Change -138.79% -168.77% 215.01%
Cash From Investing Activities $8.365M $71.95M -$21.84M
YoY Change -138.3% -168.31% 211.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $20.39M
YoY Change 400.25%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 19.64M 48.56M -580.0K
YoY Change -3486.03% -71.16% -105.65%
NET CHANGE
Cash From Operating Activities -22.17M -95.56M -12.61M
Cash From Investing Activities 8.365M 71.95M -21.84M
Cash From Financing Activities 19.64M 48.56M -580.0K
Net Change In Cash 5.836M 24.95M -35.03M
YoY Change -116.66% -788.0% 392.69%
FREE CASH FLOW
Cash From Operating Activities -$22.17M -$95.56M -$12.61M
Capital Expenditures -$103.0K $207.0K -$10.00K
Free Cash Flow -$22.06M -$95.76M -$12.60M
YoY Change 75.12% 42.82% 22.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Auditor Firm
AuditorFirmId
42
CY2021 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2021 dei Auditor Location
AuditorLocation
Redwood City, California
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34871000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9925000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
363000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
148851000
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
186350000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M2D
CY2021Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
1763000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M25D
CY2020Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
722000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1357000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2497000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
187206000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
199857000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
28651000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
63387000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
650000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
658000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4727000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5295000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y21D
CY2020Q4 us-gaap Assets
Assets
270728000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
901000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
878000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29834000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14925000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45521000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
271460265
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25678000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
30940000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
190160311
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20893000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4267000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4799000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
49830000
CY2021 us-gaap Operating Expenses
OperatingExpenses
115392000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-75617000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
24042000
CY2020 us-gaap Operating Expenses
OperatingExpenses
77166000
CY2021Q4 us-gaap Liabilities
Liabilities
99618000
CY2020Q4 us-gaap Liabilities
Liabilities
59781000
CY2019 us-gaap Operating Expenses
OperatingExpenses
72965000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-113999000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
675000000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-76913000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
323731591
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-72505000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
527000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
323731591
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
1828000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
4221000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
310566853
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
310566853
CY2021 us-gaap Interest Expense
InterestExpense
3740000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
324000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
310000
CY2020 us-gaap Interest Expense
InterestExpense
760000
CY2020 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
60000
CY2019 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-195000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1398006000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
364000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1366188000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1271741000
CY2021Q4 gern Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
4800000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8218000
CY2020Q4 gern Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
1531000
CY2021Q4 us-gaap Assets
Assets
226034000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
168000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6687000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6919000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8099000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1155629000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-69000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-173000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
78000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
126416000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
210947000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
226034000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
270728000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1393000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
253000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
460000
CY2021 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
85727000
CY2020 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
51488000
CY2019 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
52072000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29665000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-75617000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
315000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-75671000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-68233000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
177733000
CY2019 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
68000
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
204000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6079000
CY2019 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
9000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
135155000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-75617000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
6895000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-54000
CY2020 gern Public Offering Stock Issued During Period Value New Issues
PublicOfferingStockIssuedDuringPeriodValueNewIssues
140184000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4075000
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
85000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-116112000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-251000
CY2021 gern Issuance Of Common Stock In Connection With Warrant Exercise Value
IssuanceOfCommonStockInConnectionWithWarrantExerciseValue
2479000
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
91000
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
797000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8080000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
126416000
CY2020 us-gaap Profit Loss
ProfitLoss
-75617000
CY2019 us-gaap Profit Loss
ProfitLoss
-68548000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
215000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
158000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
64000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-818000
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
893000
CY2020 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
19000
CY2021 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
1233000
CY2020 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
148000
CY2020 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
-163000
CY2019 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
196000
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
91000
CY2020 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
85000
CY2019 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
68000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
8080000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
6079000
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
9000
CY2021 gern Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
568000
CY2020 gern Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
777000
CY2019 gern Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
712000
CY2021 gern Increase Decrease In Accrued Interest Receivable Net And Other Receivables
IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables
1041000
CY2020 gern Increase Decrease In Accrued Interest Receivable Net And Other Receivables
IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables
-80000
CY2019 gern Increase Decrease In Accrued Interest Receivable Net And Other Receivables
IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables
-366000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1317000
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1286000
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-121000
CY2021 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
3807000
CY2020 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
206000
CY2019 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
964000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-232000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5731000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
199000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-119000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3388000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2188000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
19295000
CY2020 gern Increase Decrease Due To Counterparty
IncreaseDecreaseDueToCounterparty
-14269000
CY2019 gern Increase Decrease Due To Counterparty
IncreaseDecreaseDueToCounterparty
11659000
CY2021 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
14909000
CY2020 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
7397000
CY2019 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
6211000
CY2021 gern Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-509000
CY2020 gern Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-452000
CY2019 gern Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-655000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-95556000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-66652000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43829000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
207000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
401000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
413000
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
177434000
CY2020 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
313201000
CY2019 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
153467000
CY2020 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
7681000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
247994000
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
200262000
CY2019 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
181280000
CY2021 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
1594000
CY2020 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
339000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
71947000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-105320000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
27400000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
797000
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
208000
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
204000
CY2020 gern Proceeds From Public Offering Issuance Of Common Stock And Warrants
ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants
140184000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20385000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4075000
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2479000
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
16000
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
24895000
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
23863000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
48556000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
168346000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19499000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
24947000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3626000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3070000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10288000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13914000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10844000
CY2021 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P4Y
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
31706000
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
31706000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
364000
CY2021Q4 us-gaap Restricted Investments At Fair Value
RestrictedInvestmentsAtFairValue
364000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
177675000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
177000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
177502000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
363000
CY2020Q4 us-gaap Restricted Investments At Fair Value
RestrictedInvestmentsAtFairValue
363000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
249659000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
111000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
33000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
249737000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
128591000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
170000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
4993000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
7000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
133584000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
177000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
56850000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
33000
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
56850000
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
33000
CY2007Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
13842625
CY2020Q3 us-gaap Business Combination Cost Of Acquired Entity Equity Interests Issued And Issuable Fair Value Method
BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod
we received 13 BARD1 shares for every five shares of Sienna ordinary shares, resulting in our ownership of 35,990,825 shares of BARD1.
CY2020Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
35990825
CY2020Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
182000
CY2020Q3 gern Number Of Shares Sold From Equity Investment
NumberOfSharesSoldFromEquityInvestment
15322939
CY2020Q3 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
339000
CY2020Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-34000
CY2020Q4 gern Equity Investment Reverse Stock Split
EquityInvestmentReverseStockSplit
1 for 30
CY2020Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
688929
CY2021Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
1233000
CY2021Q1 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
0
CY2021Q4 gern Number Of Financial Institutions
NumberOfFinancialInstitutions
5
CY2018Q3 gern Collaborative Arrangement After Termination Cost Sharing Percentage Of Entity
CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity
1
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1300000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1271000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
650000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
613000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
650000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
658000
CY2021Q4 gern Accrued Clinical Research Organizations And Clinical Trial Costs Current
AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent
22804000
CY2020Q4 gern Accrued Clinical Research Organizations And Clinical Trial Costs Current
AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent
11800000
CY2021Q4 gern Accrued Manufacturing Activities Current
AccruedManufacturingActivitiesCurrent
4123000
CY2020Q4 gern Accrued Manufacturing Activities Current
AccruedManufacturingActivitiesCurrent
1903000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2030000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
640000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
336000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
194000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
541000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
388000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29834000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14925000
CY2021 gern Loss Contingency Triggering Event Employee Termination Without Cause Following Change Of Control Period
LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod
P12M
CY2021 gern Loss Contingency Triggering Event Period Following Change Of Control During Which No Comparable Employment Is Offered By Entity
LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity
P30D
CY2021 gern Loss Contingency Triggering Event Period Following Change Of Control Within Which Employee Resigns Due To Material Change In Terms Of Employment
LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment
P12M
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
946000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
1143000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
783000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
252000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
293000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
17000
CY2021 us-gaap Lease Cost
LeaseCost
1198000
CY2020 us-gaap Lease Cost
LeaseCost
1436000
CY2019 us-gaap Lease Cost
LeaseCost
800000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4510000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
25352000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
33140000
CY2021Q4 gern Long Term Debt Gross
LongTermDebtGross
63002000
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
9727000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
863000
CY2021Q4 gern Debt Instrument Unamortized End Of Term Charge
DebtInstrumentUnamortizedEndOfTermCharge
2582000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
49830000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
675000000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
7257747
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
43663691
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.12
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
18300000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
9562106
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
9562106
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.81
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
20783
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
451853
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.23
CY2021 gern Share Based Compensation Forfeitures And Expirations In Period Net
ShareBasedCompensationForfeituresAndExpirationsInPeriodNet
2788535
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
2821535
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.31
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
18763393
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
49952409
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.06
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
890000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
30459136
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.35
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
547000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
49085603
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.06
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
878000
CY2021Q4 us-gaap Share Price
SharePrice
1.22
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
30459136
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
25721508
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
19915713
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.35
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.54
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.86
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
93000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
17000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
80000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
556000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
25000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
163000
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
12341000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8080000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6895000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6079000
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P28M
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
49952409
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
18763393
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
64108705
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
133292810
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.090
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1300000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.255
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
310700000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
277200000
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.069
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.122
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.057
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.053
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.040
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.012
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.005
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.008
CY2021 gern Effective Income Tax Rate Reconciliation Net Operating Loss Not Benefitted
EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted
-0.054
CY2020 gern Effective Income Tax Rate Reconciliation Net Operating Loss Not Benefitted
EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted
-0.069
CY2019 gern Effective Income Tax Rate Reconciliation Net Operating Loss Not Benefitted
EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted
-0.058
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.003
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.289
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.304
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
241300000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
217100000
CY2021Q4 gern Deferred Tax Assets Federal And State Credits
DeferredTaxAssetsFederalAndStateCredits
49600000
CY2020Q4 gern Deferred Tax Assets Federal And State Credits
DeferredTaxAssetsFederalAndStateCredits
42800000
CY2021Q4 gern Deferred Tax Assets Capitalized Research And Development
DeferredTaxAssetsCapitalizedResearchAndDevelopment
6900000
CY2020Q4 gern Deferred Tax Assets Capitalized Research And Development
DeferredTaxAssetsCapitalizedResearchAndDevelopment
6000000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
10200000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
9400000
CY2021Q4 gern Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
1400000
CY2020Q4 gern Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
1200000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2600000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2100000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
312000000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
278600000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1400000
CY2021Q4 gern Deferred Tax Liabilities Operating Leases Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets
1300000
CY2020Q4 gern Deferred Tax Liabilities Operating Leases Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets
1400000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1300000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1400000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
33500000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
19300000
CY2021 gern Employer Tax Receivable
EmployerTaxReceivable
1152000
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
21300000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
19100000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2200000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
21300000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-251000
CY2020 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-54000
CY2019 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
315000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3575000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2473000
CY2021 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
2704000
CY2020 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
388000

Files In Submission

Name View Source Status
0001564590-22-009627-index-headers.html Edgar Link pending
0001564590-22-009627-index.html Edgar Link pending
0001564590-22-009627.txt Edgar Link pending
0001564590-22-009627-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gern-10k_20211231.htm Edgar Link pending
gern-10k_20211231_htm.xml Edgar Link completed
gern-20211231.xsd Edgar Link pending
gern-20211231_cal.xml Edgar Link unprocessable
gern-20211231_def.xml Edgar Link unprocessable
gern-20211231_lab.xml Edgar Link unprocessable
gern-20211231_pre.xml Edgar Link unprocessable
gern-ex1014_126.htm Edgar Link pending
gern-ex1020_124.htm Edgar Link pending
gern-ex1022_125.htm Edgar Link pending
gern-ex231_7.htm Edgar Link pending
gern-ex311_8.htm Edgar Link pending
gern-ex312_11.htm Edgar Link pending
gern-ex321_9.htm Edgar Link pending
gern-ex322_6.htm Edgar Link pending
gern-ex41_123.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending